Back to Atlas
APotentially durableStandard research/education caution
CMP-0007
Not approved; prohibited in sport
4-Hydroxytestosterone
Ergogenic / AAS
Non-aromatizing androgen/anabolic effect with anti-estrogenic positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- AAS / aromatase-inhibiting androgen
- Primary mechanism
- AR agonist plus aromatase-inhibition properties; A:A ratio not well established
- Primary market use
- Designer/prohormone-market AAS
Pharmacology
- Molecular weight (Da)
- 304.43
- Oral bioavailability
- Route-dependent; oral not standard
- Half-life
- ~5–60 min parent peptide; analogs may be longer
- Route tags
- Route-dependent / verify
- Evidence level
- Research/doping literature
- Clinical status
- Not approved; prohibited in sport
- Value-for-money score
- 3 / 10
Reported protocol signal
No clean popular protocol found in uploaded sources; create as research/reference entry and verify before public protocol display.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Also related to formestane/prohormone marketing; direct ratio data sparse.